fllnrlul

m nmamu

Mpflfli

Non-Small Cell Lung
Cancer Market to 2020
- New Theranies to
Enhance Treatment
Segmentation and
D...
Introduction to Report

 

- Launch Date:  July 31,2014

- Number of Pages:  143

- Geography Coverage:  Global

- Availab...
About the Report

 

"Non-Small Cell Lung Cancer Market m 2020 - New
Yherapies m Enhance Treatment Segmentation and Drive
...
Research Finding

-The value of the Non-Small Cell Lung Cancer (NSCLC)
market is expected to increase significantly over t...
Research Finding Continues. ..

  
   
    
   
   

 

-Over the forecast period to 2020, several new additions
to the NS...
Scope

-A disease introduction,  which defines the disease and
looks at symptoms,  diagnosis and treatment

-Analysis of t...
. Scope Continues. ..

-An epidemiological forecast of the major NSCLC markets, 
In which projected values Include total a...
Rcpnri Coverage

1. Introduction

2. Marketed Products
3. NSCLC Pipeline
4. Market Forecast
5. Strategic consolidations
6....
Custom Research: 

 

-Are you an industry professional,  entrepreneur, 
venture capitalist,  investors and organization, ...
How To Buy This Report‘? 

Visit following URL to see Table of Content and
purchase this publication: 

http: IImrr. cmlZ7...
Upcoming SlideShare
Loading in …5
×

Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Market

566 views

Published on

The Non-Small Cell Lung Cancer (NSCLC) market will undergo considerable growth from $5.1 billion in 2013 to $7.9 billion in 2020 at a Compound Annual Growth Rate (CAGR) of 6.6%. See more at- http://mrr.cm/Z7K

Published in: Healthcare
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
566
On SlideShare
0
From Embeds
0
Number of Embeds
6
Actions
Shares
0
Downloads
3
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Market

  1. 1. fllnrlul m nmamu Mpflfli Non-Small Cell Lung Cancer Market to 2020 - New Theranies to Enhance Treatment Segmentation and Drive Growth in an Increasinelv Comnetitive Market Category : Pharma 8. Healthcare AH wqaxznd mg»: mentioned on mm was among lumen mwecuvr awnevx ; www. MarketResearcl1}1epur| s.cum
  2. 2. Introduction to Report - Launch Date: July 31,2014 - Number of Pages: 143 - Geography Coverage: Global - Available Format: PDF -Price For Single User License: USD 3,500 -Price For Site User License: USD 7,000 -Price For Global User License: USD 10,500 -Delivery 1'Ime: Within 24 Hours (During Working Days) $3 www. MarketResearchReports. com
  3. 3. About the Report "Non-Small Cell Lung Cancer Market m 2020 - New Yherapies m Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Market" report focuses on the increasing differentiation between the three main NSCLC subtypes: squamous cell, adenocarcinoma, and large cell carcinoma. The report assesses the current NSCLC market and predicts market trends to 2020, analyxing key drivers and barriers. www. MarketResearchReports. com
  4. 4. Research Finding -The value of the Non-Small Cell Lung Cancer (NSCLC) market is expected to increase significantly over the forecast period across the leading eight developed nations, from $5.1 billion in 2013 to $7.9 billion in 2020. -This equates to a Compound Annual Growth Rate (CAGR) of 6.6%. Growth will be driven by novel therapies entering the squamous cell carcinoma market segment, which is currently lacking effective treatment, unlike the non- squamous market segment. -New second-line therapies include immunostimulants such as ramucirumab and nivolumab, which have shown clinical benefits, but which will face difficulties due to the increasingly crowded second-line setting. Currently, pharmaceutical treatment is limited to late-stage patients.
  5. 5. Research Finding Continues. .. -Over the forecast period to 2020, several new additions to the NSCLC treatment paradigm will transform the treatment landscape. Many of these will he monoclonal Antibodies (mAhs), which instigate an immune response to the tumor rather than directly affecting cancer cells. -Squamous cell hinology accounts for approximately 30% of the NSCLC population, and pipeline products, such as Vervoy (ipilimumah) in the first-line treatment and nivolumah in the second-line, will add greater diversity to the treatment algorithm, with both having shown clinical benefits in early-stage trials.
  6. 6. Scope -A disease introduction, which defines the disease and looks at symptoms, diagnosis and treatment -Analysis of the NSCLC marketed landscape, including a comparison of the efficacy and safety of the most prominent brands, as well as the unmet needs of NSCLC treatment -Detailed analysis of the NSCLC pipeline, covering among other parameters, drug distribution by Phase, molecule type and mechanism of action. The NSCLC clinical trial landscape is analyxed with particular emphasis on failure rates across different trial Phases, as well as the trends in clinical trial site, duration and primary endpoint. -This section also includes profiles and single product forecasts for the most promising pipeline drugs.
  7. 7. . Scope Continues. .. -An epidemiological forecast of the major NSCLC markets, In which projected values Include total and treated populations -An In-depth forecanlng model for the NSCLC market, which considers the current marketed therapies In ‘ ‘‘ addition to the potential entry of new products to the l market. The model comprises a projected outcome with performance of pipeline therapies. -Analysis of strategic consolidations within the NSCLC Indication, Including co-development and licensing agreements -An overview of the drivers of and barriers to the NSCLC market ‘ high and low variance results depending on the potential www. MarketResearchReports. com
  8. 8. Rcpnri Coverage 1. Introduction 2. Marketed Products 3. NSCLC Pipeline 4. Market Forecast 5. Strategic consolidations 6. Appendix For more umhsvquflnl wan mun! meme nu snne mgaqgxzm ». .,g. ;_m. nm. ,a 0., im: shd_- mpug aan. _.u m}nhc1w-Vuwnlrx :5 www. MarketResearchReports. com
  9. 9. Custom Research: -Are you an industry professional, entrepreneur, venture capitalist, investors and organization, then let us know your specific research requirements. Our goal is to cater to your requirements be it for a custom market research project, syndicated research report on a specific market or industry sector, newsletter creation, case study development or anything else related to marketing research. For Any (. ‘uslun| iL1lion Related query v‘ ‘ Ideal‘/ enter as 1m : www. rnarketrese.1rcl1re m. com id. ea—cenler
  10. 10. How To Buy This Report‘? Visit following URL to see Table of Content and purchase this publication: http: IImrr. cmlZ7K About Market Research Reports, Inc. Market Research Fleports provides a customized set of reports from reputed Publishers, built on the intelligence available within organizations and leverages on our motto of “Intelligence Redefined". Contac Amitava Sen ' f mrketre rch . m +1 302-703-7737 (USA) +91—8762746600 (India) M ; , www. MarketResearchReports. com

×